First Time Loading...

LogicBio Therapeutics Inc
NASDAQ:LOGC

Watchlist Manager
LogicBio Therapeutics Inc Logo
LogicBio Therapeutics Inc
NASDAQ:LOGC
Watchlist
Price: 5.29 USD 1.24% Market Closed
Updated: May 29, 2024

LogicBio Therapeutics Inc
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

LogicBio Therapeutics Inc
Other Long-Term Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
LogicBio Therapeutics Inc
NASDAQ:LOGC
Other Long-Term Assets
$622k
CAGR 3-Years
61%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Long-Term Assets
$9.1B
CAGR 3-Years
24%
CAGR 5-Years
51%
CAGR 10-Years
27%
Gilead Sciences Inc
NASDAQ:GILD
Other Long-Term Assets
$4.8B
CAGR 3-Years
-4%
CAGR 5-Years
14%
CAGR 10-Years
25%
Amgen Inc
NASDAQ:AMGN
Other Long-Term Assets
$9B
CAGR 3-Years
16%
CAGR 5-Years
39%
CAGR 10-Years
19%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Long-Term Assets
$2.8B
CAGR 3-Years
49%
CAGR 5-Years
13%
CAGR 10-Years
75%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Long-Term Assets
$3.2B
CAGR 3-Years
55%
CAGR 5-Years
27%
CAGR 10-Years
29%

See Also

What is LogicBio Therapeutics Inc's Other Long-Term Assets?
Other Long-Term Assets
622k USD

Based on the financial report for Dec 31, 2021, LogicBio Therapeutics Inc's Other Long-Term Assets amounts to 622k USD.

What is LogicBio Therapeutics Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 3Y
61%

Over the last year, the Other Long-Term Assets growth was 0%. The average annual Other Long-Term Assets growth rates for LogicBio Therapeutics Inc have been 61% over the past three years .